
Rallis India Reports 9% Revenue Growth in FY26, Achieves Highest EBITDA of ₹ 362 Crore
Mumbai, April 27, 2026: Rallis India Limited, a leading player in the Indian agri inputs industry and a TATA Enterprise, announced its financial results for the quarter and the full financial year ending March 31, 2026. The company reported strong growth metrics, highlighting a 9% revenue increase in Fiscal Year 2026 (FY26).During the year, Rallis India Limited reported total revenue of ₹ 2,897 crore, marking a significant increase compared to the previous year’s ₹ 2,663 crore. The company also achieved its highest-ever EBITDA of ₹ 362 crore, coupled with improved EBITDA margins of 12.5%. Profit After Tax (PAT) stood at ₹ 184 crore, up from ₹ 125 crore the previous year.
Dr. Gyanendra Shukla, Managing Director & CEO of Rallis India Limited, noted that the steady performance during FY26 was supported by broad-based growth across key business segments and successful margin improvements, which he attributed to volume growth and cost optimization initiatives.
Business Performance Highlights
The company's performance across key segments showed varied growth patterns during the reporting periods.Full Year FY26 Performance:
- Crop Care: The business grew by 8%, with the Domestic Formulations segment contributing 5% growth based on steady performance across core brands.
- B2B Exports: This segment, including Custom Synthesis Manufacturing (CSM), saw a robust 17% growth. This expansion was supported by volume growth in the International Business Division and improved realizations across key molecules.
- Soil and Plant Health (SPH): Despite regulatory challenges relating to Biostimulants, the SPH segment delivered an 8% growth, driven by focused product placement and demand generation initiatives.
- Seeds: The Seeds business grew by 15%, demonstrating resilience amid supply constraints and demand challenges in major crops such as Cotton and Mustard.
Quarterly Performance (Q4 FY26):
For the quarter, Rallis recorded a 6% year-on-year revenue growth, stemming from 5% volume growth and 1% price growth. The Seeds business delivered particularly strong growth of 23%.
Segmentally for Q4 FY26:
- Crop Care: The business grew by 5%. The B2C segment showed strong growth of 15%, while the B2B segment experienced a 7% decline due to lower volumes.
- Key Highlights: In Crop Protection, the company strengthened its product portfolio by launching two new insecticide products: Fiplam and Alstor. Additionally, the company achieved its highest-ever production levels of select products, driven by improved manufacturing efficiency and operational excellence.
Market Commentary and Outlook
Commenting on the results, Dr. Gyanendra Shukla reiterated that the FY26 performance reflects the company's ongoing commitment to strengthening the business through focused execution, portfolio expansion, and enhancing customer engagement. He stated that the focus moving forward would remain on building on product portfolio strength, digital capabilities, and the innovation pipeline to drive sustainable growth.Rallis India Limited Overview
Rallis India Limited is a subsidiary of Tata Chemicals Limited and forms part of the over US$ 180 billion Tata Group. Recognized as one of India's premier agri science companies, Rallis boasts over 77 years of experience serving Indian farmers. The company is known for its deep understanding of Indian agriculture, its established connect with farmers, and a comprehensive product portfolio encompassing quality agrochemicals and seeds. Rallis operates through a vast distribution network comprising 7,200 dealers and over 95,000 retailers nationwide. Furthermore, Rallis is recognized for its manufacturing capabilities and ability to develop new processes and formulations, making it a preferred contract manufacturing partner for global corporations.RALLIS Stock Price Movement
Today, Rallis India Limited shares rallied to close at ₹261.27, finishing the trading session up 2.05% for the day. The stock saw robust buying interest, supported by a total volume of 299,848 shares traded.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.